News2020-06-06T12:18:49-04:00

Advaita Bioinformatics News

A leader in the interpretation of high-throughput biomedical data.

iPathwayGuide’s prediction for a COVID-19 drug validated in clinical study

April 28, 2020|In the Press, iPathwayGuide, Updates|

Methylprednisolone effective in treating critically ill patients Recently, we announced that Advaita’s advanced AI platform, iPathwayGuide, was able to predict an existing drug with clinical efficacy against COVID-19. While the manuscript undergoes peer review, a preprint is available from Nature Research. Read [...]

Advaita’s iPathwayGuide provides a cost-effective alternative to Ingenuity Pathway Analysis (IPA) on Yet Another Continent

October 14, 2019|In the Press, iPathwayGuide, iVariantGuide, Updates|

Inqaba Biotechnical Industries partners with Advaita Bioinformatics to provide advanced pathway analysis software in Sub-Saharan Africa ANN ARBOR, MI – October 14, 2019— Advaita Bioinformatics, the leader in the interpretation of high-throughput biomedical data, today announced a new distribution partnership [...]

iPathwayGuide Analysis Finds Both Overlapping and Species-Specific Endocrine Disrupting Chemical Response Signatures in Sardine and Mackerel

April 27, 2019|iPathwayGuide, Updates|

Orthologs in Systems Biology A recent paper by Renaud, et al., (Environmental Pollution, Vol 244, January 2019, pp 926-937) points out the significant hazard posed by endocrine disrupting chemical (EDC) exposure for aquatic organisms.  Renaud, et al., employed iPathwayGuide as [...]

AdvaitaBio releases a new version of iPathwayGuide, the world’s most advanced RNA-seq and gene expression analysis software

November 8, 2018|iPathwayGuide, Updates|

Advaita Bioinformatics is announcing a new release of iPathwayGuide, the world’s most advanced RNA-seq and gene expression analysis software. This release includes unprecedented gene network analysis and literature mining capabilities. The newly added network analysis capabilities allow the scientists to [...]

Load More Posts
Advaita Bioinformatics

About Advaita Bioinformatics

Advaita Bioinformatics is a leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, disease subtype discovery and integration of multiple data types. Currently, 9 of the top 10 pharma companies rely on Advaita’s state-of-the-art algorithms to solve complex problems. Advaita was founded by Sorin Draghici, a professor at Wayne State University, and provides a suite of advanced analysis software to more that 13,000 registered users worldwide: iPathwayGuide, for functional interpretation of genes and proteins; iVariantGuide, for genetic variant analysis; and iBioGuide, a search engine revealing connections between genes, pathways, SNPs, drugs, and more. Sorin Draghici is also the CEO of Advaita Bioinformatics.

Subscribe to Our Newsletter
SUBSCRIBE TO ADVAITA UPDATES AND NEWSLETTERS